Evidence map›Paper›PMID 31506575›Full record

ArticleScientific reports2019

Annurca apple polyphenol extract selectively kills MDA-MB-231 cells through ROS generation, sustained JNK activation and cell growth and survival inhibition.

Elisa Martino, Daniela Cristina Vuoso, Stefania D'Angelo, Luigi Mele, Nunzia D'Onofrio, Marina Porcelli, Giovanna Cacciapuoti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Polyphenol-enriched fraction ofFrontiers in pharmacology · 2026
    Article
  3. Biocompatible Copolymerized Gold Nanoclusters: Anti-Biomimetics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Effects ofOxidative medicine and cellular longevity · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elisa MartinoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via Luigi De Crecchio 7, 80138, Naples, Italy.
Daniela Cristina VuosoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via Luigi De Crecchio 7, 80138, Naples, Italy.
Stefania D'AngeloDepartment of Motor Sciences and Wellness, "Parthenope" University, via Medina 40, 80133, Naples, Italy.
Luigi MeleDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138, Naples, Italy.
Nunzia D'OnofrioDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via Luigi De Crecchio 7, 80138, Naples, Italy.
Marina PorcelliDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via Luigi De Crecchio 7, 80138, Naples, Italy.
Giovanna CacciapuotiDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via Luigi De Crecchio 7, 80138, Naples, Italy. giovanna.cacciapuoti@unicampania.it.
University of Campania "Luigi Vanvitelli" · ITParthenope University of Naples · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyphenols represent the most studied class of nutraceuticals that can be therapeutics for a large spectrum of diseases, including cancer. In this study, we investigated for the first time the antitumor activities of polyphenol extract from Annurca apple (APE) in MDA-MB-231 triple negative breast cancer cells, and we explored the underlying mechanisms. APE selectively inhibited MDA-MB-231 cell viability and caused G2/M phase arrest associated with p27 and phospho-cdc25C upregulation and with p21 downregulation. APE promoted reactive oxygen species (ROS) generation in MDA-MB-231 cells while it acted as antioxidant in non-tumorigenic MCF10A cells. We demonstrated that ROS generation represented the primary step of APE antitumor activity as pretreatment with antioxidant N-acetylcysteine (NAC) prevented APE-induced G2/M phase arrest, apoptosis, and autophagy. APE downregulated Dusp-1 and induced a significant increase in JNK/c-Jun phosphorylation that were both prevented by NAC. Moreover, downregulation of JNK by its specific inhibitor SP600125 significantly diminished the anticancer activity of APE indicating that ROS generation and sustained JNK activation represented the main underlying mechanism of APE-induced cell death. APE also inhibited AKT activation and downregulated several oncoproteins, such as NF-kB, c-myc, and β-catenin. In light of these results, APE may be an attractive candidate for drug development against triple negative breast cancer.

Indexed as

Antineoplastic Agents, PhytogenicAntioxidantsApoptosisAutophagyBiomarkersCell Line, TumorCell ProliferationCell SurvivalChlorogenic AcidFemaleFlavonoidsG2 Phase Cell Cycle CheckpointsHumansJNK Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemReactive Oxygen SpeciesAntineoplastic Agents, PhytogenicAntioxidantsapple polyphenol extractBiomarkersChlorogenic AcidFlavonoidsJNK Mitogen-Activated Protein KinasesReactive Oxygen SpeciesTanninsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID31506575
PMCPMC6736874
OpenAlexW2972646348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.